A landmark ruling by the Bombay High Court has clarified that the gestational limit of 24 weeks under the Medical Termination of Pregnancy Act, 1971, does not apply when a Medical Board confirms a substantial risk of severe, lifelong morbidity in the fetus due to congenital abnormality. The Court permitted termination at 34 weeks, affirming that the autonomy of the pregnant woman and expert medical opinion override rigid time-based restrictions when the statutory condition of serious fetal anomaly is met.
Background & Facts
The Dispute
The petitioners, a 37-year-old pregnant woman (petitioner no.1) and her husband (petitioner no.2), sought permission to terminate a pregnancy at approximately 33 - 34 weeks gestation after a fetal anomaly was detected. The woman had a history of two prior caesarean sections and one treated ectopic pregnancy. Initial assessment at District Hospital, Thane, concluded that the fetal condition was compatible with postnatal survival, albeit requiring specialized neonatal care. Dissatisfied with this conclusion and concerned about the potential for severe lifelong disability, the petitioners approached the Bombay High Court.
Key Facts
- The petitioner is 37 years old and currently at 33 - 34 weeks gestation as of 27.03.2026
- Obstetric ultrasonography revealed non-lethal skeletal dysplasia with severe shortening of all long bones (<1st centile), macrocephaly (HC and BPD >95th centile), mild bowing of long bones, ulnar deviation of right hand, and possible rocker-bottom foot
- Fetal weight estimated at 1.8 kg at 36 weeks gestation
- Multiple specialist opinions confirmed the fetus would likely be born alive and require intensive neonatal care (NICU)
- The condition is associated with multiple corrective surgeries, chronic morbidity, and significant mental and physical disability
- The petitioner and her husband expressed a clear, informed desire for feticide in utero prior to delivery
- The Psychiatry Department confirmed the petitioner is not suffering from any psychiatric illness
- Sir J.J. Group of Hospitals and Grant Medical College, Mumbai, constituted a Medical Board on 26.03.2026 at the Court’s direction
- The Medical Board’s report, signed by the Chairman and members from Radiology, Pediatric Surgery, Gynecology & Obstetrics, and Psychiatry, unanimously concluded the fetus is affected by a serious congenital abnormality
Procedural History
- 15.03.2026: Initial medical assessment at District Hospital, Thane, concluded no life-threatening abnormality; condition compatible with survival
- 20.03.2026: Petitioners filed Writ Petition No. 3992 of 2026 before the Bombay High Court seeking permission for termination
- 26.03.2026: Court directed referral to Sir J.J. Group of Hospitals for a Medical Board evaluation
- 27.03.2026: Medical Board submitted its report, recommending termination due to substantial risk of severe lifelong morbidity
- 27.03.2026: Oral arguments heard before Justices Bharati Dangre and Manjusha Deshpande
The Parties' Positions
The petitioners argued that the Medical Board’s unanimous opinion met the threshold under Section 3(2)(b) of the MTP Act, 1971, as amended in 2021, and that Rule 3-B and Rule 3-A of the MTP Rules, 2003, explicitly permit termination beyond 24 weeks in cases of serious fetal malformation. They emphasized the woman’s right to bodily autonomy and the irreversible nature of the child’s anticipated suffering.
The Respondents, the Union of India and the State, did not oppose the petition. The Government Advocate acknowledged the Medical Board’s findings and did not contest the legal interpretation advanced by the petitioners.
Relief Sought
The petitioners sought permission to terminate the pregnancy through feticide in utero prior to delivery, at a tertiary care center of their choice, in accordance with the MTP Act and Rules, and requested the Court to direct that the procedure be carried out without delay.
The Legal Issue
The central question was whether Section 3(2)(b) of the Medical Termination of Pregnancy Act, 1971, as amended in 2021, permits termination of pregnancy beyond 24 weeks when a Medical Board confirms a substantial risk that the child, if born, would suffer from serious physical or mental abnormalities leading to severe handicap, irrespective of gestational age.
Arguments Presented
For the Petitioner
Ms. Meenaz Kakalia submitted that Section 3(2)(b) does not impose a gestational cap when the condition involves a substantial risk of serious fetal abnormality. She relied on Rule 3-B(f) of the MTP Rules, 2003, which explicitly includes fetal malformation with substantial risk of severe handicap as a category eligible for termination up to 24 weeks. She further invoked Rule 3-A(i), which empowers Medical Boards to permit termination beyond 24 weeks where fetal malformation poses such risk. She cited the Government of India’s Guidance Note on termination beyond 20 weeks, which endorses feticide via potassium chloride injection under ultrasound guidance for such cases. She emphasized that the Act’s purpose is to prevent the birth of children with severe disabilities, and rigid time limits cannot override this objective when the medical evidence is unequivocal.
For the Respondent
The Respondents did not contest the petition. Ms. Anusha Amin and Mrs. M.P. Thakur accepted the Medical Board’s findings and acknowledged the legal framework supporting termination under the amended Act and Rules. They did not advance any counter-argument.
The Court's Analysis
The Court undertook a detailed textual and purposive interpretation of the Medical Termination of Pregnancy Act, 1971, as amended by the 2021 Act, and the corresponding Rules. It noted that Section 3(2)(b) permits termination where there is a substantial risk that the child, if born, would suffer from physical or mental abnormalities leading to serious handicap. The Court held that this provision does not contain any gestational ceiling, and the 20-week limit in Section 3(2)(a) applies only to cases not falling under clause (b).
"The length of pregnancy is irrelevant when such termination is necessitated by the diagnosis of any of the substantial fetal abnormalities diagnosed by a Medical Board."
The Court emphasized that Rule 3-B(f) explicitly extends eligibility to termination up to 24 weeks for fetal malformations with substantial risk of severe handicap. Further, Rule 3-A(i) confers upon Medical Boards the authority to permit termination beyond 24 weeks where the same condition exists. The Court found that the Medical Board’s unanimous opinion - supported by detailed reports from Radiology, Obstetrics, Pediatrics, and Psychiatry - satisfied both the diagnostic threshold and procedural requirements.
The Court also noted the Board’s recognition of the petitioner’s autonomy and informed consent, and its recommendation for feticide in utero, consistent with the Government’s Guidance Note and RCOG protocols. The Court observed that the fetus, though non-lethal, would face lifelong suffering requiring multiple surgeries and intensive care, and that the parents’ desire to avoid such suffering was both ethically and legally valid.
The Court rejected any notion that the 24-week limit acts as a hard barrier in cases of severe fetal anomaly, stating that such an interpretation would defeat the very purpose of the 2021 amendment, which was to expand access in cases of serious fetal malformation.
The Verdict
The petition succeeded. The Court permitted petitioner no.1 to terminate the pregnancy by performing feticide in utero prior to delivery. The procedure must be carried out at a tertiary care center of the petitioners’ choice, compliant with Rule 5 of the MTP Rules, 2003, and under ultrasound guidance. The Court directed that the procedure be conducted expeditiously. The petitioners were allowed to choose a private hospital for the procedure, at their own risk and consequence. The Court declined to entertain the challenge to Form No. A at this stage, leaving it open for future litigation.
What This Means For Similar Cases
Substantial Fetal Abnormality Overrides Gestational Limits
- Practitioners may now confidently argue that Section 3(2)(b) and Rule 3-A(i) create a standalone pathway for termination beyond 24 weeks when a Medical Board confirms a serious fetal malformation
- The 24-week limit under Rule 3-B applies only to eligibility; it does not cap the right to terminate when the condition meets the statutory threshold
- Courts must prioritize medical opinion over arbitrary timeframes in cases of severe fetal anomaly
Medical Board Opinions Are Conclusive and Binding
- A unanimous, well-documented opinion from a duly constituted Medical Board satisfies the legal requirement under Rule 3-A
- Separate specialist reports, when consistent, strengthen the evidentiary foundation and cannot be disregarded on procedural grounds
- The absence of a life-threatening condition does not disqualify a case - the statutory test is serious handicap and morbidity, not mortality
Autonomy and Informed Consent Are Central to the Legal Framework
- The Court’s explicit recognition of the patient’s desire for feticide in utero affirms reproductive autonomy as a core component of the MTP Act’s interpretation
- Feticide prior to delivery, as recommended by the Board and aligned with RCOG guidelines, is now legally recognized as a valid medical procedure under the Act
- Petitioners must be allowed to choose the facility for the procedure, even if private, provided it meets Rule 5 standards
